( ) has seen a significant increase in short-term interest in the month of march. On March 31, there were 31100 shares of short interest, which is an increase of 88.5 % from the total of 16 500 shares on March 15. The short-interest rate is 311.0 days based on an average daily volume of 100 shares.
Sartorius Stedim Biotech Stock Performance
The price of the stock remained unchanged at $312.50 on Friday during trading hours. The 50-day average price of the firm is $343.04, and its 200-day average price is 330.23. Separately on Monday 23rd January, Credit Suisse Group began coverage of shares of Sartorius Stedim Biotech. The company was given a neutral rating. Three analysts at equities firms have given the company's shares a buy or hold rating. According to MarketBeat the stock has a current consensus rating of "Moderate Buy" and an average target price of $448.33.
Sartorius Stedim Biotech
Sartorius Stedim Biotech SA offers equipment and services to the biopharmaceutical sector for development, quality control, and production. The company offers a wide range of products that focus on all stages of the manufacturing of a biopharmaceutical as well as process development procedures as prerequisites.
MarketBeat.com offers a FREE daily email newsletter